Linguistic and clinical validation of the acute cystitis symptom score in German-speaking Swiss women with acute cystitis

Alidjanov, Jakhongir F; Khudaybergenov, U. A.; Ayubov, Bekhzod A; Pilatz, Adrian; Mohr, Stefan; Münst, Julia; Yuen, Olivia N Ziviello; Pilatz, Sabine; Christmann-Schmid, Corina; Dittmar, Florian; Mirsaidov, N; Buch-Heberling, Mareike; Naber, Kurt G.; Johansen, Truls E. Bjerklund; Wagenlehner, Florian

doi:10.1007/s00192-021-04864-1

Cited by 4 publications

(3 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As expected, the two groups, patients and controls, differed statistically significantly regarding prevalence and severity of typical symptoms of AC. For the Greek patients a sum score of ≥6 of the typical symptoms showed also the best diagnostic odds ratio as with other languages in which the ACSS was tested clinically as well [14][15][16][17][18][19]. Therefore, the ACSS could now also be used in multilingual studies, in which the ACSS was validated linguistically and also tested clinically.…”

Section: Discussionmentioning

confidence: 94%

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS)—Part II

et al. 2021

Self Cite

View full text Add to dashboard Cite

The Acute Cystitis Symptom Score (ACSS) is a patient self-reporting questionnaire for the clinical diagnosis and patient-reported outcome (PRO) in women with acute uncomplicated cystitis (AC). The aim of the current study (part II) is the clinical validation of the Greek ACSS questionnaire. After linguistic validation according to internationally accepted guidelines and cognitive assessment (part I), the clinical validation was performed by using the Greek ACSS study version in 92 evaluable female participants including 53 patients with symptoms suspicious of AC and 39 controls. The clinical outcome using the ACSS questionnaire at different points in time after the start of treatment was demonstrated as well. The age (mean ± SD) of the 53 patients (44.7 ± 17.0 years) and 39 controls (49.3 ± 15.9 years) and their additional conditions at baseline visits, such as menstruation, premenstrual syndrome, pregnancy, menopause, diabetes mellitus, were comparable. There was, however, a significant difference (p < 0.001) between patients and controls at baseline visit regarding sum score of the ACSS domains, such as typical symptoms and quality of life. The clinical outcome of up to 7 days showed a fast reduction of the symptom scores and improvement of quality of life. The optimal thresholds for the patient-reported outcome of successful therapy could be established. The linguistically and clinically validated Greek ACSS questionnaire can now be used for clinical or epidemiological studies and also for patients’ self-diagnosis of AC and as a PRO measure tool.

show abstract

Section: Discussionmentioning

confidence: 94%

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS)—Part II

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…After translation and cognitive assessment [13], the Greek version of the ACSS was now also tested clinically in 53 female patients diagnosed with AC by the treating physician according to national and international guidelines and compared with the results of 39 controls without a suspected diagnosis of UTI. As expected for the prevalence and severity of typical symptoms of AC there was a significant statistical difference between the two groups in which also for the Greek patients a sum score of >6 of the typical symptoms showed the best diagnostic odds ratio as with other languages in which the ACSS was tested clinically as well [14][15][16][17][18][19]. Therefore, the ACSS could now also be used in multilingual studies, in which the ACSS was validated linguistically and also tested clinically.…”

Section: Discussionmentioning

confidence: 67%

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS). Part II

Stamatiou¹,

Samara²,

Alidjanov³

et al. 2021

Preprint

Self Cite

View full text Add to dashboard Cite

The Acute Cystitis Symptom Score (ACSS) is a patient self-reporting questionnaire for the clinical diagnosis and patient-reported outcome (PRO) in women with acute uncomplicated cystitis (AC). The aim of the current study (part II) was the clinical validation of the Greek ACSS questionnaire. After linguistic validation according to internationally accepted guidelines and cognitive assessment (part I), the clinical validation was performed after ethical approval by using the Greek ACSS study version in 92 evaluable female participants including 53 patients with symptoms suspicious of AC and 39 controls. The clinical outcome using the ACSS questionnaire at different time points after the start of treatment was demonstrated as well. The age (mean±SD) of the 53 patients (44.7±17.0) and 39 controls (49.3±15.9) and their additional conditions at baseline visits, such as menstruation, premenstrual syndrome, pregnancy, menopause, diabetes mellitus, were comparable. There was, however, a significant difference (p&lt;0.001) between patients and controls at baseline visit regarding sum score of the ACSS domains, such as typical symptoms and quality of life. The clinical outcome of up to 7 days showed a fast reduction of the symptom scores and improvement of quality of life. The optimal thresholds for the patient-reported outcome of successful therapy could be established. The linguistically and clinically validated Greek ACSS questionnaire can now be used for clinical or epidemiological studies and also for patient’s self-diagnosis of AC and as a PRO measure tool.

show abstract

“… Alidjanov et al [ 27 ] Very good (+/+) Alidjanov et al [ 28 ] Doubtful (+) Alidjanov et al [ 29 ] Adequate (+) Alidjanov et al [ 30 ] Doubtful (+) Alidjanov et al [ 31 ] Very good (+), Doubtful (+) Alidjanov et al [ 32 ] Doubtful (?) Alidjanov et al [ 33 ] Very good (+), Doubtful (–) Very good (+) Alidjanov et al [ 34 ] Very good (–), Adequate (–) Very good (+) Bruyère et al [ 35 ] …”

Section: Resultsmentioning

confidence: 99%

Patient-reported outcome measures for uncomplicated urinary tract infections in women: a systematic review

et al. 2023

View full text Add to dashboard Cite

Purpose To conduct a systematic review of the quality of existing patient-reported outcome measures (PROMs) for use in women with uncomplicated urinary tract infections (UTIs) applying the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology, and to derive recommendations for their use in future research. Methods A systematic literature search was performed in PubMed and Web of Science. Studies reporting on the development and/or validation of any PROMs for uncomplicated UTIs in women were considered eligible. We evaluated the methodological quality of each included study using the COSMIN Risk of Bias Checklist, and further applied predefined criteria for good measurement properties. Finally, we graded the evidence and derived recommendations for the use of the included PROMs. Results Data from 23 studies reporting on six PROMs were included. From those, the Acute Cystitis Symptom Score (ACSS) and the Urinary Tract Infection-Symptom and Impairment Questionnaire (UTI-SIQ-8) can be recommended for further use. Both instruments showed sufficient content validity. We further found high-quality evidence for sufficient internal consistency of the UTI-SIQ-8, while this criterion was not assessed for the ACSS due to a formative measurement model. All other PROMs have the potential to be recommended for use, but require further validation. Conclusion The ACSS and the UTI-SIQ-8 have the potential to be recommended for use in women with uncomplicated UTIs in future clinical trials. For all included PROMs, further validation studies are indicated. Systematic review registration: PROSPERO.

show abstract

Linguistic and clinical validation of the acute cystitis symptom score in German-speaking Swiss women with acute cystitis

Cited by 4 publications

References 42 publications

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS)—Part II

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS)—Part II

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS). Part II

Patient-reported outcome measures for uncomplicated urinary tract infections in women: a systematic review

Contact Info

Product

Resources

About